Lv5
1000 积分 2023-06-03 加入
Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30‐day outcomes in the elderly
10小时前
已完结
Vulnerable or High-Risk Plaque
1个月前
已完结
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial
2个月前
已完结
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction
2个月前
已完结
Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes
2个月前
已完结
Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial
2个月前
已完结
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial
2个月前
已完结
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
3个月前
已完结
The Science of Frailty
3个月前
已完结
PRECISE-DAPT, ARC-HBR, or Simplified Clinical Evaluation for the Prediction of Major Bleeding After Percutaneous Coronary Intervention in older Patients
3个月前
已完结
皖公网安备34019202002308
